838 related articles for article (PubMed ID: 28662830)
1. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.
Chen J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():87-165. PubMed ID: 28662830
[TBL] [Abstract][Full Text] [Related]
2. Placental growth factor reverses decreased vascular and uteroplacental MMP-2 and MMP-9 and increased MMP-1 and MMP-7 and collagen types I and IV in hypertensive pregnancy.
Ren Z; Cui N; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2018 Jul; 315(1):H33-H47. PubMed ID: 29569955
[TBL] [Abstract][Full Text] [Related]
3. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
Shah DA; Khalil RA
Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
[TBL] [Abstract][Full Text] [Related]
4. Decreased uterine vascularization and uterine arterial expansive remodeling with reduced matrix metalloproteinase-2 and -9 in hypertensive pregnancy.
Lin C; He H; Cui N; Ren Z; Zhu M; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Jan; 318(1):H165-H180. PubMed ID: 31834839
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.
Possomato-Vieira JS; Khalil RA
Adv Pharmacol; 2016; 77():361-431. PubMed ID: 27451103
[TBL] [Abstract][Full Text] [Related]
6. Vascular mechanisms and molecular targets in hypertensive pregnancy and preeclampsia.
Qu H; Khalil RA
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H661-H681. PubMed ID: 32762557
[TBL] [Abstract][Full Text] [Related]
7. Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.
Li W; Cui N; Mazzuca MQ; Mata KM; Khalil RA
Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H491-H507. PubMed ID: 28626073
[TBL] [Abstract][Full Text] [Related]
8. TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats.
Ren Z; Cui N; Zhu M; Khalil RA
Biochem Pharmacol; 2021 Nov; 193():114790. PubMed ID: 34600915
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic imbalance and diminished matrix metalloproteinase-2 and -9 underlie regional decreases in uteroplacental vascularization and feto-placental growth in hypertensive pregnancy.
Dias-Junior CA; Chen J; Cui N; Chiang CL; Zhu M; Ren Z; Possomato-Vieira JS; Khalil RA
Biochem Pharmacol; 2017 Dec; 146():101-116. PubMed ID: 28912068
[TBL] [Abstract][Full Text] [Related]
10. Altered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.
Li W; Mata KM; Mazzuca MQ; Khalil RA
Biochem Pharmacol; 2014 Jun; 89(3):370-85. PubMed ID: 24704473
[TBL] [Abstract][Full Text] [Related]
11. Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.
Chen J; Ren Z; Zhu M; Khalil RA
Biochem Pharmacol; 2017 Aug; 138():81-95. PubMed ID: 28506758
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of microvascular dysfunction in hypertensive pregnancy and preeclampsia.
Yu W; Gao W; Rong D; Wu Z; Khalil RA
Microcirculation; 2018 Oct; ():e12508. PubMed ID: 30338879
[TBL] [Abstract][Full Text] [Related]
13. Role of ADAM and ADAMTS disintegrin and metalloproteinases in normal pregnancy and preeclampsia.
Qu H; Khalil RA
Biochem Pharmacol; 2022 Dec; 206():115266. PubMed ID: 36191626
[TBL] [Abstract][Full Text] [Related]
14. EMMPRIN-mediated induction of uterine and vascular matrix metalloproteinases during pregnancy and in response to estrogen and progesterone.
Dang Y; Li W; Tran V; Khalil RA
Biochem Pharmacol; 2013 Sep; 86(6):734-47. PubMed ID: 23856290
[TBL] [Abstract][Full Text] [Related]
15. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
Yagel S; Cohen SM; Goldman-Wohl D
Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
[TBL] [Abstract][Full Text] [Related]
16. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.
Reslan OM; Khalil RA
Cardiovasc Hematol Agents Med Chem; 2010 Oct; 8(4):204-26. PubMed ID: 20923405
[TBL] [Abstract][Full Text] [Related]
17. New Insights into the Role of Matrix Metalloproteinases in Preeclampsia.
Espino Y Sosa S; Flores-Pliego A; Espejel-Nuñez A; Medina-Bastidas D; Vadillo-Ortega F; Zaga-Clavellina V; Estrada-Gutierrez G
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726716
[TBL] [Abstract][Full Text] [Related]
18. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
Holme AM; Roland MC; Henriksen T; Michelsen TM
Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
[TBL] [Abstract][Full Text] [Related]
19. Expression of Matrix Metalloproteinases in the Mouse Uterus and Human Myometrium During Pregnancy, Labor, and Preterm Labor.
Lombardi A; Makieva S; Rinaldi SF; Arcuri F; Petraglia F; Norman JE
Reprod Sci; 2018 Jun; 25(6):938-949. PubMed ID: 28950743
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.
Sheppard SJ; Khalil RA
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):33-52. PubMed ID: 20041838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
